Review of a dose-dependent increase in mortality with vesnarinone among patients with severe heart failure.
LeJemtel
T H
TH
Department of Medicine, Division of Cardiology, Albert Einstein College of Medicine of Yeshiva University, Bronx, New York, USA.
D002316:Cardiotonic Agents / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D006333:Heart Failure / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D011719:Pyrazines; D011804:Quinolines / Q000008:administration & dosage*; D016019:Survival Analysis
D002316:Cardiotonic Agents; D011719:Pyrazines; D011804:Quinolines; C041667:vesnarinone